Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Trident Texofab has informed that it enclosed Earnings Presentation for the quarter ended on September 30, 2021 (Q2FY22).
The above information is a part of company’s filings submitted to BSE.